How certain is your international normalized ratio? Measurement uncertainty, the new WHO thromboplastin standard, and what we should know. [PDF]
MacDonald S.
europepmc +1 more source
Individual Comparative PK Evaluation of Single-dose Octocog Alfa, Rurioctocog Alfa Pegol, and Efanesoctocog Alfa in Adults with Severe Hemophilia A. [PDF]
Staber JM +5 more
europepmc +1 more source
The role of coagulation parameters in the assessment of acute pancreatitis severity: A retrospective study. [PDF]
Zhu H, Hong M, Hu W, Yu Q.
europepmc +1 more source
Case Report: Differential diagnosis and clinical management of isolated prolonged activated partial thromboplastin time. [PDF]
Liu L, Guo D.
europepmc +1 more source
Management of Bleeding Disorder During Dual Antiplatelet Therapy. [PDF]
Madaudo C, Galassi AR, VadalĂ G.
europepmc +1 more source
Appropriateness of terlipressin use and its association with clinical efficacy and safety: A real-world cohort study of 240 hospitalized patients. [PDF]
Peng Y, Duan H, Li M, Xiang K, Li J.
europepmc +1 more source
Exploring Coagulation Abnormalities and Functional Impairment in Long COVID: Relevance to Primary Care Practice. [PDF]
Chikkala RKP +5 more
europepmc +1 more source
Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Antithrombotic-Treated Cardiac Patients: A Cross-Sectional Study from Sana'a City, Yemen. [PDF]
Amer AH, Al-Adhroey AH, Al-Shammakh AA.
europepmc +1 more source

